Associazione E.R.ME.S.

home
publications
who are we?
news
tradictions
where you can find us

 

 

last update on

26/09/2007

 

 

 

 

Italian site

come back to Italian version

ermes-news:

Two important publications of prof. Maurizio Bifulco and dr. Paolo Cavallo underline scientific importance of the medieval Medical School of Salerno rules

 

next events:

FARMACEDUCA®: educational project for drugs administration

 

 

NEWS:

 

 

  • July 6, 2006

    According to a paper just advertised in the Molecular Pharmacology by prof. Maurizio Bifulco research group there is a new therapeutic targer for Rimonabant (Sanofi-aventis).

    Get the full information here -> pubmed

     

    June 29, 2006

    (ANSA) - Rome, June 27 - A little village perched on a mountainside in the
    Italian Alps could help researchers identify a gene which protects people from diabetes and high blood pressure. Extensive tests have shown that the 402 inhabitants of Stoccareddo, near Asiago in the northeastern region, seem to have an immunity to these ailments. This fact, coupled with records showing centuries of marriages exclusively within the isolated community, has led a group of medical researchers to suspect the presence of a protective gene. "It seems a likely explanation. These people seem to have the basic conditions for certain diseases but none of the consequences," said Anna Baschirotto, joint founder of the Baschirotto Foundation which is carrying out the research.


     

  • May 29, 2006

Delta-9-tetrahydrocannabinol (THC) exhibits anti-tumor effects on various cancer cell types, but its use in chemotherapy is limited by its psychotropic activity. Results obtained in a panel of tumor cell lines clearly indicate that the non-psychoactive cannabidiol is the most potent inhibitor of cancer cell growth. Both cannabidiol and the cannabidiol-rich extract inhibited the growth, and reduced lung metastases in animal models. These data support the further testing of cannabidiol and cannabidiol-rich extracts for the potential treatment of cancer.
Get the full information here -> pubmed

 

  • May 16, 2006

According to a recent study carried out by Hancox and Poulton from University of Otago, New Zeland, watching television is associated with childhood obesity.

Get the full information here -> pubmed

 

  • March 6, 2006

    The FASEB Journal has published an important Maurizio Bifulco's and Chiara Laezza's research on a new natural compound, named N6-isopentenyladenosine, a cytokinin that has shown an antiproliferative effect on cancer cells. 

    more informations here ->pubmed

     

  • February 26, 2006

    Sanofi-Aventis programs to invest about 114.000.000 euro till 2008 for its Italian factories, 63.000.000 euro for its Italian Phase I clinical trials and 27.000.000 euro for its basic research laboratory in Milan.

     
  • Paris (FRA), February 17, 2006

The FDA (Food and Drug Administration), Division of Metabolism and Endocrinology Products has sent to Sanofy-Aventis (the producer of the compound) an approvable letter for Rimonabant for weight management. Meanwhile, on the other hand, the Division of Anesthesia, Analgesia and Rheumatology Products has sent a non approvable letter for smoking cessation.

Copy and distribution of this site items is only permitted on demand
Copyright © 2004 Associazione ERMES

Via Toledo, 265, 80132 Napoli, Italy

Telefono/Fax: +39 081.19570099 email: info@associazioneermes.it
To contribute go here
credits